1. Skip to Main Menu
  2. Skip to Content
  3. Skip to Footer
Last Updated:Sunday 10 February 2013, 14:49

DLIFE

About dLife: The Diabetes Health Company

dLife was established to address the overwhelming consumer need for real, practical solutions to the 24/7 challenge of managing diabetes vs. episodic clinical treatment.
dLife is all about diabetes in real life
  • Empower self-management via creative consumer mechanisms
  • Deliver engagement in consumer's daily life stream at point of need vs. point of care
  • Consider the whole person - especially emotional, motivational, and practical needs


In other words, break out of the clinical box and put it in their hands.

Since it's inception in 2004, dLife has become the premiere platform to inform, inspire, and connect with millions of diabetes patients, consumers, and caregivers and in the process positively impact engagement and ultimately health outcome.
dLife's award-winning media outlets include dLife.com, the leading online diabetes destination attracting over one million unique visitors each month and featuring the widest and deepest variety of original content and resources anywhere; dLifeTV, the only TV series dedicated to people with diabetes with almost half a million viewers, airing every Sunday on CNBC (7 p.m. ET, 4 p.m. PT), dLife Mobile applications, and other consumer and professional programs driving proactive diabetes self-management with improved health outcome.

Response from Congressman John Lewis

Dear Mr. Walker:

Thank you for contacting me to express your support for increasing federal funding for health research and disease prevention programs. My heart goes out to all who suffer from chronic illnesses and debilitating medical conditions. I firmly believe the government has a moral obligation to stand by our courageous brothers and sisters by caring for them and promoting medical advancements that will fight and cure disease.

 

I have always been a strong and vocal supporter of full funding for the National Institute of Health (NIH) and Centers for Disease Control (CDC), which I'm proud to say is headquartered in Georgia's fifth district. Research done by these institutions is vital to the health of all Americans. A firm commitment to the NIH and CDC is a commitment to treating, curing, and preventing the most debilitating medical conditions of our time.

 

Stem Cell research is another area in which I believe we can make great progress in combating serious illnesses. As you know, a vast majority of experts believe that embryonic stem cells are the best hope of curing a host of complex diseases. I am a strong supporter of ethical stem cell research and the role that it can play in the advancement of health and medical research. We must provide doctors and patients with the most advanced research to fight these terrible diseases.

 

I will continue to fight for better treatment and care for patients with serious medical ailments. A strong government commitment to the best medical research represents our best hope for curing - among other things - cancer, diabetes, and AIDS. Thank you again for contacting me about this incredibly important issue. I hope that you will continue to share your views with me. Also, please visit my web site at  http://www.house.gov/johnlewis/ for information on other issues of interest to you.


Sincerely,

John  Lewis
Member of Congress

 


Message from Senator Chambliss

Dear Mr. Walker:
Thank you for contacting me regarding future funding levels for diabetes research programs. It is good to hear from you.

As you know, diabetes is a devastating disease that is growing at an epidemic speed. In 1980, 5.76 million Americans were diagnosed with diabetes. Currently, The American Diabetes Association reports that 25.8 million Americans have diabetes.

I am committed to ensuring that all Americans with diabetes have access to the necessary care required to combat the disease. It is also important that we continue to devote adequate resources to diabetes research. Recently, I signed a letter sent to the Commissioner of the Food and Drug Administration urging them to move quickly on the next phase of research for the artificial pancreas. This device is an important advancement in medical technology that could reduce the complications that individuals with diabetes face on a daily basis by enabling patients to monitor and control their glucose levels with more accuracy and precision.

The final fiscal year (FY) 2011 Continuing Resolution included $30.7 billion for the National Institute of Health (NIH), and the President's proposed budget for FY 2012 includes $31.83 billion for the NIH and $5.89 billion for the Centers for Disease Control and Prevention (CDC). I understand the vital importance of the roles the NIH and CDC play in our country's constant battle to find cures for not only terminal diseases, but also the non-life threatening diseases that many Americans struggle with on a daily basis.

I believe that Congress must take a thorough look at the entire federal budget to find ways to resolve our nation's fiscal crisis. As we seek to make these difficult decisions and the Senate proceeds to consideration of the FY 2012 budget, I will keep your thoughts and views in mind.

If you would like to receive timely email alerts regarding the latest congressional actions and my weekly e-newsletter, please sign up via my web site at: www.chambliss.senate.gov.

Please let me know whenever I may be of assistance.


Mission Statement

Mission statement

Our mission is to provide ongoing information and community education in diabetes mellitus by advocating for daily exercise and food modifications in the diets of adults and kids. The overall goal is to combine resources with other agencies to reduce diabetes mellitus in public and private schools by 10% percent over the next 5 years in the state of Georgia.


ADAP Takes Diabetes Advocacy to South Africa

ATLANTA, GA., Thursday, September 20, 2012 ----On Sunday, September 23, 2012, members of the Atlanta Diabetes & Prevention Group (ADPG) will travel to Capetown, South Africa, to participate in the Capetown Marathon.

Following Chicago, Paris and Rio de Janeiro, the 42 km Capetown run, which began in 2007, presents the fourth opportunity for ADPG to spread its message on the importance of diabetes awareness and prevention while lobbying the world for a cure.

 

Founded in 2011, by DeVry University & Phoenix University professor and former Atlanta School Board candidate--Donald Walker, ADPG is a non-profit, action oriented advocacy organization with a mission to: Provide literature to schools and communities; Lobby legislators for healthier school lunch meals; Push for international cooperation resulting in greater awareness and prevention of diabetes, along the way to a cure by calling attention to it all via marathons.

 

Walker is no stranger to Diabetes. Four years ago he collapsed into a coma, becoming insulin dependent. But after incorporating lifestyle and mindset changes into his daily living, Walker's participation in marathons is now far more than ADPG's mission. For him it's personal!

 

"As an organization, we are committed to running a marathon on every continent. We want others to know that through a modified diet, increased exercise, and greater education in the area of nutrition, diabetes can often be managed. With a carefully and professionally monitored philosophy of living, medications and needles are often eliminated from treatment," explains Walker.

 

Atlanta Diabetes & Prevention Group actively seeks volunteers and contributions in support of its mission and goals. By visiting www.atlantadap.org, you can help make a difference.

 

For your enjoyment and information about this “Action Non-Profit organization,” please visit the following link to a recent feature on running, as recently published in Business Traveler Magazine...

http://www.businesstravelerusa.com/archive/2012-2/march-2012/lifestyle/running-the-world


ADAP on Twitter